FDA Approved: FOSAPREPITANT — Supplemental Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for fosaprepitant submitted by Novadoz Pharmaceuticals LLC to expand its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

SUPPL AP for FOSAPREPITANT (FOSAPREPITANT)